Table 1.
Animals examined in this study
| Stage and animal# | Sex | Age | Days after SIV | Route of Inoc. | CD4 counts | Plasma viral load | Diagnosis |
|---|---|---|---|---|---|---|---|
| Control | |||||||
| AG71 | F | 11 | NA1 | NA1 | 796 | NA1 | NSL2 |
| BB01 | F | 13 | NA1 | NA1 | 2430 | NA1 | NSL2 |
| BE84 | F | 11 | NA1 | NA1 | 2454 | NA1 | NSL2 |
| CC10 | F | 15 | NA1 | NA1 | 1720 | NA1 | NSL2 |
| GN58 | F | 13 | NA1 | NA1 | 480 | NA1 | NSL2 |
| GN70 | F | 10 | NA1 | NA1 | 1091 | NA1 | NSL2 |
| GN74 | F | 13 | NA1 | NA1 | 585 | NA1 | NSL2 |
| N483 | F | 16 | NA1 | NA1 | 602 | NA1 | NSL2 |
|
| |||||||
| Acute | |||||||
| HI52 | F | 5 | 7 | IV3 | 664 | 3,700,600 | NSL2 |
| AV63 | F | 4 | 8 | IV3 | 463 | 24,310,900 | Lymphoid hyperplasia |
| BA57 | F | 14 | 8 | IV3 | 416 | 14,288,200 | Lymphoid hyperplasia |
| HI53 | F | 7 | 8 | IV3 | 325 | 3,555,700 | Lymphoid hyperplasia |
| T108 | F | 13 | 8 | IV3 | 653 | 57,314 | Lymphoid hyperplasia |
| BV13 | M | 3 | 8 | IV3 | 752 | 16,000,000 | Lymphoid hyperplasia |
| AV91 | M | 14 | 10 | IV3 | 472 | 157,190,000 | Lymphoid hyperplasia |
| L880 | M | 11 | 10 | IV3 | 212 | 7,000,000 | Lymphoid hyperplasia |
| C419 | M | 20 | 10 | IV3 | 383 | 11,000,000 | NSL2 |
| HI58 | F | 7 | 12 | IV3 | 651 | 8,496,000 | Lymphoid hyperplasia |
| HI63 | F | 7 | 12 | IV3 | 438 | 24,310,900 | Lymphoid hyperplasia |
| T139 | M | 7 | 13 | IV3 | 355 | 3,200,000 | Lymphoid hyperplasia |
| BA17 | M | 8 | 13 | IV3 | 416 | 11,000,000 | Lymphoid hyperplasia |
| M992 | F | 16 | 13 | IV3 | 227 | 34,949,800 | Lymphoid hyperplasia |
| AV85 | F | 8 | 21 | IV3 | 670 | 230,000 | Lymphoid hyperplasia |
| CB74 | F | 3 | 21 | IV3 | 992 | 2,100,000 | Lymphoid hyperplasia |
| BI58 | M | 3 | 21 | IV3 | 558 | 12,000,000 | Lymphoid hyperplasia |
| BN37 | M | 3 | 21 | IV3 | 542 | 340,000 | Lymphoid hyperplasia |
|
| |||||||
| Chronic | |||||||
| N998 | F | 10 | 180 | INVG4 | 584 | 427,600 | Lymphoid hyperplasia |
| R908 | F | 9 | 181 | INVG4 | 653 | 4,700 | Lymphoid hyperplasia |
| CF35 | M | 5 | 91 | IR5 | 546 | 121,680 | Lymphoid hyperplasia |
| BV74 | M | 5 | 63 | IR5 | 775 | 3,111 | Lymphoid hyperplasia |
| DI28 | M | 3 | 80 | IR5 | 810 | 3,064 | Lymphoid hyperplasia |
| DL31 | M | 3 | 128 | IR5 | 1332 | 54,500 | Lymphoid hyperplasia |
| DB53 | M | 5 | 77 | IR5 | 277 | 28,560 | Lymphoid hyperplasia |
| DE09 | M | 4 | 76 | IR5 | 1192 | 5,088 | Lymphoid hyperplasia |
| HG49 | F | 11 | 145 | INVG4 | 184 | 104,945 | Lymphoid hyperplasia |
| FK47 | M | 5 | 98 | IR5 | 459 | ND | Lymphoid hyperplasia |
| FD49 | M | 5 | 110 | IR5 | 318 | ND | Lymphoid hyperplasia |
| I553 | F | 11 | 646 | IV3 | 21 | 1,895,400 | AIDS; Pneumocystis inf. |
| R544 | F | 9 | 414 | INVG4 | 190 | 1,700,000 | AIDS: meningoencephalitis |
| AP53 | F | 6 | 63 | IV | 1127 | 4,100,000 | AIDS; bacterial septicemia |
| DJ18 | M | 7 | 173 | IV3 | 649 | ND | Lymphoid hyperplasia |
| HG45 | F | 14 | 148 | IV3 | 191 | 964,152 | AIDS; Pneumocystis inf. |
| HG58 | F | 11 | 283 | INVG4 | 351 | 7,074 | AIDS; encephalitis |
| HG56 | F | 10 | 152 | INVG4 | 339 | 19,522,700 | AIDS; Gsstric lymphoma |
| FA14 | F | 9 | 1068 | IV3 | 224 | 148,965 | AIDS; Pneumocystis inf. |
| HI68 | F | 10 | 155 | INVG4 | 22 | 8,076,200 | AIDS: CMV infection |
| BD78 | M | 4 | 205 | IV3 | 729 | 86,000 | AIDS; Vasculitis, thrombosis |
| BE65 | M | 6 | 1071 | IV3 | 288 | 480,000 | AIDS: M avium inf |
| T196 | M | 7 | 230 | IV3 | 270 | 750,000 | AIDS; Pneumocystis inf. |
| FE53 | M | 4 | 140 | IR5 | 469 | 343,459 | AIDS; hepatitis, gastroenteritis |
1
Not applicable
2
No significant lesions
3
Intravenous
4
Intravaginal
5
Intrarectal
6
Viremic but levels not determined at time of necropsy